The killing effects of 4-S-cysteinylcatechol and analogues on human melanoma cells
1988

Killing Effects of 4-S-Cysteinylcatechol on Melanoma Cells

Sample size: 5 publication Evidence: high

Author Information

Author(s): I. Yamada, S. Seki, S. Ito, O. Matsubara, S. Suzuki, T. Kasuga

Primary Institution: Tokyo Medical and Dental University

Hypothesis

4-S-cysteinylcatechol and its analogues are more effective in killing human melanoma cells compared to L-dopa.

Conclusion

4-S-cysteinylcatechol is a remarkably potent agent in killing human melanoma cells compared to L-dopa.

Supporting Evidence

  • 4-S-cysteinylcatechol had a Do value of 0.01 mg/ml, showing potent killing effects on melanoma cells.
  • L-dopa had a Do value of 3.16 mg/ml, indicating it is considerably weak in killing melanoma cells.
  • 2-S-Cysteinylhydroquinone had a Do value of 0.035 mg/ml, making it the second most effective compound tested.

Takeaway

Scientists found that a new chemical, 4-S-cysteinylcatechol, is much better at killing skin cancer cells than an older medicine called L-dopa.

Methodology

The study involved synthesizing new compounds and testing their effects on human melanoma cells in vitro by measuring cell survival after drug exposure.

Participant Demographics

Human melanoma cell line derived from a malignant melanoma in a woman.

Statistical Information

P-Value

<0.01

Statistical Significance

p<0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication